Press Releases

Prof. Jeanette Erdmann from the German Center for Cardiovascular Research (DZHK) and the University of Lübeck receives the "BIH Excellence Award for Sex and Gender Aspects in Health Research 2021" from the Berlin Institute of Health (BIH) in the Charité. Together with two BIH...

Fat cells are much more than simply a calorie storage for scarce times. DZHK scientist Alexander Bartelt studies the role of healthy fat cells in metabolism and what happens when they become aggressive, for example when they overflow after too much food and too little exercise....

People with a thickened heart muscle (cardiac hypertrophy) have a thinner cerebral cortex and white matter damage. Scientists from the German Center for Cardiovascular Research (DZHK) at the Greifswald University Medical Center have recognized this connection between the heart...

Scientists at the German Center for Cardiovascular Research (DZHK) have discovered a new biomarker for estimating the risk of another heart attack or death after an index heart attack. The biomarker 'Cellular Communication Network Factor 1' (CCN1), which can be measured in blood...

Immediate angiograms are not necessary, and can even cause worse outcomes, after a cardiac arrest where there is no obvious cause. These are the results presented from the TOMAHAWK-DZHK4 stud at the European Congress of Cardiology, published simultaneously in the New England...

After a heart attack, an implanted heart monitor can better detect those at risk of serious complications, when compared to conventional follow-up care. This is the result of a study by researchers from the German Centre for Cardiovascular Research, presented at the European...

SARS-CoV-2 infection can weaken the heart, but it recovers in most patients after two months. Munich scientists from the German Centre for Cardiovascular Research (DZHK) and the LMU Hospital have shown this in hospitalised COVID-19 patients.

An inhibitor of a fat-degrading protein can protect against heart failure. Researchers at the German Centre for Cardiovascular Research (DZHK) at the Charité – Universitätsmedizin Berlin were able to show this in mice. It is remarkable that the inhibitor does not act directly in...

The global cardiovascular research community is joining forces: eleven leading and independent funding organisations from Australia, Canada, Denmark, France, Germany, New Zealand, the Netherlands, Sweden, and the United Kingdom have joined forces to form the Global Cardiovascular...

Temporarily discontinuing ACE inhibitors and angiotensin receptor blockers does not affect the severity of COVID-19 disease, but it could have a beneficial effect on the recovery phase. Pausing could be particularly useful in elderly cardiovascular patients, suggest the authors...